UBS Group
ARRY

UBS Group’s Array Biopharma Inc ARRY Stock Holding History

UBS Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-95,000
Closed -$700K – 9031
2015
Q1 		$700K Buy
95,000
+93,300
+5,488% +$664K ﹤0.01% 3875
2014
Q4 		$8K Buy
+1,700
New +$6.72K ﹤0.01% 8642

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group's ARRY Position: Q3 2019 in Review

UBS Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,301,849 shares — an estimated $60.3M sold.

UBS Group first reported a position in ARRY in Q4 2014 and held it in 19 quarters. The position peaked at $60.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • UBS Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • UBS Group sold 1,301,849 Array Biopharma Inc shares in Q3 2019, an estimated $60.3M.
  • UBS Group first reported a position in Array Biopharma Inc in Q4 2014 and held it in 19 quarters.
  • UBS Group's Array Biopharma Inc position peaked at $60.3M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.